CN104707041B - For the care drug of postoperation - Google Patents
For the care drug of postoperation Download PDFInfo
- Publication number
- CN104707041B CN104707041B CN201510091681.1A CN201510091681A CN104707041B CN 104707041 B CN104707041 B CN 104707041B CN 201510091681 A CN201510091681 A CN 201510091681A CN 104707041 B CN104707041 B CN 104707041B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- effect
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention discloses a kind of care drug for postoperation, comprise following raw material medicaments: Radix Sophorae Flavescentis, Natrii Sulfas, Radix Paeoniae Rubra, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Salviae Miltiorrhizae, Radix Sanguisorbae, Radix Ilicis Pubescentis, Galla Chinensis, Fructus Cnidii, Flos Chrysanthemi, the Fructus Kochiae, Rhizoma Atractylodis Macrocephalae (parched), Radix Platycodonis, Fructus Toosendan, Rhizoma Corydalis, Herba Artemisiae Scopariae, Rhizoma Smilacis Glabrae and Bulbus Fritillariae Thunbergii.In medicine of the present invention, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, Radix Sanguisorbae, the Pseudobulbus Bletillae (Rhizoma Bletillae) have effect of heat clearing and blood circulation promoting, cooling blood for hemostasis; The Rhizoma Atractylodis Macrocephalae, Rhizoma Smilacis Glabrae, Fructus Toosendan, Rhizoma Corydalis have effect of promoting the circulation of QI for relieving swelling pain relieving; Natrii Sulfas, Radix Sophorae Flavescentis have effect of softening the hard mass removing dampness; Bulbus Fritillariae Thunbergii, Herba Artemisiae Scopariae punt-pole, Radix Platycodonis have effect of removing heat from blood detumescence; Galla Chinensis, Fructus Cnidii, the Fructus Kochiae have detumescence and promoting granulation, promote effect of wound healing; Radix Ilicis Pubescentis, Flos Chrysanthemi have the effect strengthening clearing away heat and cooling blood; Effect that all crude drug are played together altogether " promoting blood circulation and cooling blood stops blooding, promoting the circulation of QI for relieving swelling pain relieving ", effectively shortens healing time, alleviates the misery of patient.
Description
Technical field
The present invention relates to a kind of care drug for postoperation.
Background technology
Hemorrhoid (being commonly called as hemorrhoid) are a kind of common diseases being positioned at anus position, and its clinical manifestation is: have blood in stool, falling inflation, pain, deviate from anus, swelling, pruritus, generation thrombosis etc.
At present mainly (traditional operation and Minimally Invasive Surgery are comprised) based on operative treatment to the Therapeutic Method of hemorrhoid.Although the operation of hemorrhoid is fairly simple, risk is also smaller, but, location comparison residing for hemorrhoid is hidden, postoperatively easily to develop complications, as: Anal edema, pain etc., these complication not only affect the quality of life of patient, and the effect of hemorrhoid operation can be had a strong impact on, be unfavorable for postoperative rehabilitation.
At present, potassium permanganate demibain is mainly used to the postoperative care of hemorrhoid.Potassium permanganate is a kind of Strong oxdiative thing, has pain relieving of itching, protects from infection, promotes the effect that the blood stasis deviate from resets.But, through clinical trial, find that potassium permanganate demibain can not slow down the pain symptom of postoperative patient, and after the demibain of use potassium permanganate, easily occur the symptom such as Flora Disturbance, injured skin.
Summary of the invention
The object of the present invention is to provide a kind of care drug for postoperation, with at least one in solving the problem.
According to an aspect of the present invention, provide a kind of care drug for postoperation, comprise following raw material medicaments: Radix Sophorae Flavescentis, Natrii Sulfas, Radix Paeoniae Rubra, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Salviae Miltiorrhizae, Radix Sanguisorbae, Radix Ilicis Pubescentis, Galla Chinensis, Fructus Cnidii, Flos Chrysanthemi, the Fructus Kochiae, Rhizoma Atractylodis Macrocephalae (parched), Radix Platycodonis, Fructus Toosendan, Rhizoma Corydalis, Herba Artemisiae Scopariae, Rhizoma Smilacis Glabrae and Bulbus Fritillariae Thunbergii.
In the embodiment that some are concrete, medicine of the present invention can preferably include the crude drug of following mass parts: Radix Sophorae Flavescentis 10 ~ 20 parts, 10 ~ 20 parts, Natrii Sulfas, Radix Paeoniae Rubra 15 ~ 25 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 15 ~ 25 parts, Radix Salviae Miltiorrhizae 15 ~ 25 parts, Radix Sanguisorbae 15 ~ 25 parts, Radix Ilicis Pubescentis 15 ~ 25 parts, Galla Chinensis 10 ~ 20 parts, Fructus Cnidii 25 ~ 35 parts, Flos Chrysanthemi 10 ~ 20 parts, the Fructus Kochiae 10 ~ 20 parts, Rhizoma Atractylodis Macrocephalae (parched) 10 ~ 20 parts, Radix Platycodonis 5 ~ 15 parts, Fructus Toosendan 10 ~ 20 parts, Rhizoma Corydalis 15 ~ 25 parts, Herba Artemisiae Scopariae 15 ~ 25 parts, Rhizoma Smilacis Glabrae 15 ~ 25 parts and Bulbus Fritillariae Thunbergii 5 ~ 15 parts.
In the embodiment that some are concrete, medicine of the present invention can preferably include the crude drug of following mass parts: Radix Sophorae Flavescentis 15 parts, 15 parts, Natrii Sulfas, Radix Paeoniae Rubra 20 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 20 parts, Radix Salviae Miltiorrhizae 20 parts, Radix Sanguisorbae 20 parts, Radix Ilicis Pubescentis 20 parts, Galla Chinensis 15 parts, Fructus Cnidii 30 parts, Flos Chrysanthemi 15 parts, the Fructus Kochiae 15 parts, Rhizoma Atractylodis Macrocephalae (parched) 15 parts, Radix Platycodonis 10 parts, Fructus Toosendan 15 parts, Rhizoma Corydalis 20 parts, Herba Artemisiae Scopariae 20 parts, Rhizoma Smilacis Glabrae 20 parts and Bulbus Fritillariae Thunbergii 10 parts.
In medicine of the present invention, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, Radix Sanguisorbae, the Pseudobulbus Bletillae (Rhizoma Bletillae) have effect of heat clearing and blood circulation promoting, cooling blood for hemostasis; The Rhizoma Atractylodis Macrocephalae, Rhizoma Smilacis Glabrae, Fructus Toosendan, Rhizoma Corydalis have effect of promoting the circulation of QI for relieving swelling pain relieving; Natrii Sulfas, Radix Sophorae Flavescentis have effect of softening the hard mass removing dampness; Bulbus Fritillariae Thunbergii, Herba Artemisiae Scopariae punt-pole, Radix Platycodonis have effect of removing heat from blood detumescence; Galla Chinensis, Fructus Cnidii, the Fructus Kochiae have detumescence and promoting granulation, promote effect of wound healing; Radix Ilicis Pubescentis, Flos Chrysanthemi have the effect strengthening clearing away heat and cooling blood; Effect that all crude drug are played together altogether " promoting blood circulation and cooling blood stops blooding, promoting the circulation of QI for relieving swelling pain relieving ", effectively shortens healing time, alleviates the misery of patient.
According to another aspect of the present invention, additionally provide a kind of care drug for postoperation, comprise the water extract of above-mentioned raw materials medicine and pharmaceutically acceptable carrier.Wherein, this medicine can be made into water preparation, powder, spray, suppository, unguentum and lotion, with the needs of satisfied transport, storage, use.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described in more detail.
List component and the ratio of the embodiment of the present invention 1 ~ 8 in table 1, in table 2, list component and the ratio of the embodiment of the present invention 9 ~ 16.
| Embodiment 1 | Embodiment 2 | Embodiment 3 | Embodiment 4 | Embodiment 5 | Embodiment 6 | Embodiment 7 | Embodiment 8 | |
| Radix Sophorae Flavescentis | 10 | 13 | 12 | 15 | 20 | 18 | 14 | 17 |
| Natrii Sulfas | 10 | 12 | 10 | 15 | 20 | 18 | 20 | 15 |
| Radix Paeoniae Rubra | 15 | 22 | 20 | 20 | 25 | 18 | 15 | 25 |
| The Pseudobulbus Bletillae (Rhizoma Bletillae) | 15 | 17 | 15 | 20 | 25 | 23 | 25 | 20 |
| Radix Salviae Miltiorrhizae | 15 | 17 | 19 | 20 | 25 | 23 | 22 | 24 |
| Radix Sanguisorbae | 15 | 22 | 20 | 20 | 25 | 18 | 15 | 25 |
| Radix Ilicis Pubescentis | 15 | 22 | 15 | 20 | 25 | 18 | 25 | 20 |
| Galla Chinensis | 10 | 13 | 15 | 15 | 20 | 18 | 10 | 20 |
| Fructus Cnidii | 25 | 28 | 25 | 30 | 35 | 32 | 30 | 35 |
| Flos Chrysanthemi | 10 | 13 | 15 | 15 | 20 | 18 | 10 | 20 |
| The Fructus Kochiae | 10 | 12 | 10 | 15 | 20 | 18 | 20 | 15 |
| Rhizoma Atractylodis Macrocephalae (parched) | 10 | 13 | 15 | 15 | 20 | 18 | 10 | 20 |
| Radix Platycodonis | 15 | 8 | 5 | 10 | 5 | 12 | 10 | 13 |
| Fructus Toosendan | 10 | 13 | 12 | 15 | 20 | 18 | 14 | 17 |
| Rhizoma Corydalis | 15 | 17 | 20 | 20 | 25 | 23 | 15 | 25 |
| Herba Artemisiae Scopariae | 15 | 22 | 17 | 20 | 25 | 18 | 24 | 23 |
| Rhizoma Smilacis Glabrae | 15 | 17 | 15 | 20 | 25 | 23 | 25 | 20 |
| Bulbus Fritillariae Thunbergii | 5 | 12 | 10 | 10 | 15 | 8 | 5 | 15 |
Table 1 (unit: mass parts)
Medicine of the present invention is mainly for the postoperative patient carrying out hemorrhoid operation.During use, with the water of 2 ~ 5 liters, the medicine in table 1 can be decocted, after decoction is as 1 ~ 3 premium on currency, fumigation and wash method is carried out to the Anal surgical of postoperative patient, every day 1 ~ 2 time.Concrete operating process is as follows: the medicine soup after decocting is placed in crissum intelligence fumigation and wash method instrument (fluid temperature is 40 ~ 50 DEG C), after vapours to be generated, patient is allowed to be seated on crissum intelligence fumigation and wash method instrument, first fumigate Anal surgical 3 ~ 5 minutes by the vapours of medicinal liquid, then by push button, make medicinal liquid auto-flushing anus 10 ~ 15 minutes, open oven dry button after stifling flushing, Anal surgical is dried (about 2 minutes).Then, irradiate crissum otch with infrared therapy apparatus, distance wound surface about 30cm, irradiation time is about 20 minutes, changes dressings routinely after having irradiated.
In addition, can also extract above-mentioned raw materials medicine with water, water extract and pharmaceutically acceptable carrier (as: water, starch) are made water preparation, powder, spray, unguentum and lotion, to facilitate transport, store and use.During use, water preparation or powder can be put into boiled water, after stirring, fumigation and wash method be carried out to the Anal surgical of postoperative patient until medicament dissolution.Spray, unguentum and lotion then can directly spray or spread upon on Anal surgical.
In order to prove the effect of medicine of the present invention, carry out following control experiment, and by experimental result log 2.
Postoperative patient in table 2, Post operation is dosed administration all routinely, and administrated method is identical with dosage, and medication comprises: Cefodizime, metronidazole intravenous drip, prop up 3d with etamsylate, vitamin K1 vein, the oral and anorectal training of rhubarb soda tablet is changed dressings to wound healing.
Experimental group: second day after operation brings into use medicine of the present invention to carry out fumigation and wash method, every day each 1 time sooner or later, continuous 5 days.The medicine of embodiment 1 ~ 8 is decocted respectively, medicine soup after decocting is placed in crissum intelligence fumigation and wash method instrument (fluid temperature is 40 ~ 50 DEG C), after vapours to be generated, patient is allowed to be seated on crissum intelligence fumigation and wash method instrument, first fumigate Anal surgical 4 minutes by the vapours of medicinal liquid, then by push button, make medicinal liquid auto-flushing anus 10 minutes, open oven dry button after stifling flushing, Anal surgical is dried (about 2 minutes).Then, irradiate crissum otch with infrared therapy apparatus, distance wound surface about 30cm, irradiation time is about 20 minutes, changes dressings routinely after having irradiated.
Matched group: second day after operation starts demibain, every day each 1 time sooner or later, continuous 5 days.Use potassium permanganate external sheet, be mixed with the aqueous solution of 1:5000 (mass concentration), solution is placed in demibain (solution temperature is 40 ~ 50 DEG C), each demibain time is 20 minutes.Open after demibain and Anal surgical is dried (about 2 minutes).Then, irradiate crissum otch with infrared therapy apparatus, distance wound surface about 30cm, irradiation time is about 20 minutes, changes dressings routinely after having irradiated.
Table 2
As can be seen from Table 2, in medicine of the present invention, there is good effect to postoperative pain, edema, bleeding, effectively decrease the pain of postoperative patient, there is detumescence and promoting granulation, promote effect of wound healing effectively to shorten healing time.
Above-described is only one embodiment of the present invention.For the person of ordinary skill of the art, without departing from the concept of the premise of the invention, can also make some distortion and improvement, these all belong to protection scope of the present invention.
Claims (4)
1. for the care drug of postoperation, it is characterized in that, its effective ingredient is made up of the crude drug of following mass parts:
Radix Sophorae Flavescentis 10 ~ 20 parts, 10 ~ 20 parts, Natrii Sulfas, Radix Paeoniae Rubra 15 ~ 25 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 15 ~ 25 parts, Radix Salviae Miltiorrhizae 15 ~ 25 parts, Radix Sanguisorbae 15 ~ 25 parts, Radix Ilicis Pubescentis 15 ~ 25 parts, Galla Chinensis 10 ~ 20 parts, Fructus Cnidii 25 ~ 35 parts, Flos Chrysanthemi 10 ~ 20 parts, the Fructus Kochiae 10 ~ 20 parts, Rhizoma Atractylodis Macrocephalae (parched) 10 ~ 20 parts, Radix Platycodonis 5 ~ 15 parts, Fructus Toosendan 10 ~ 20 parts, Rhizoma Corydalis 15 ~ 25 parts, Herba Artemisiae Scopariae 15 ~ 25 parts, Rhizoma Smilacis Glabrae 15 ~ 25 parts and Bulbus Fritillariae Thunbergii 5 ~ 15 parts.
2. the care drug for postoperation according to claim 1, is characterized in that, its effective ingredient is made up of the crude drug of following mass parts:
Radix Sophorae Flavescentis 15 parts, 15 parts, Natrii Sulfas, Radix Paeoniae Rubra 20 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 20 parts, Radix Salviae Miltiorrhizae 20 parts, Radix Sanguisorbae 20 parts, Radix Ilicis Pubescentis 20 parts, Galla Chinensis 15 parts, Fructus Cnidii 30 parts, Flos Chrysanthemi 15 parts, the Fructus Kochiae 15 parts, Rhizoma Atractylodis Macrocephalae (parched) 15 parts, Radix Platycodonis 10 parts, Fructus Toosendan 15 parts, Rhizoma Corydalis 20 parts, Herba Artemisiae Scopariae 20 parts, Rhizoma Smilacis Glabrae 20 parts and Bulbus Fritillariae Thunbergii 10 parts.
3. for the care drug of postoperation, it is characterized in that, be made up of the water extract of crude drug described in claim 1 or 2 and pharmaceutically acceptable carrier.
4. the care drug for postoperation according to claim 3, is characterized in that, described medicine is water preparation, powder, spray, suppository and unguentum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510091681.1A CN104707041B (en) | 2015-02-28 | 2015-02-28 | For the care drug of postoperation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510091681.1A CN104707041B (en) | 2015-02-28 | 2015-02-28 | For the care drug of postoperation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104707041A CN104707041A (en) | 2015-06-17 |
| CN104707041B true CN104707041B (en) | 2016-01-06 |
Family
ID=53407085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510091681.1A Expired - Fee Related CN104707041B (en) | 2015-02-28 | 2015-02-28 | For the care drug of postoperation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104707041B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105521329A (en) * | 2015-12-24 | 2016-04-27 | 邵明红 | Cleaning nursing liquid after hemorrhoids operation |
| CN106309665A (en) * | 2016-08-29 | 2017-01-11 | 山东省华鹏发展有限公司 | Musk hemorrhoid-diminishing spraying agent |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1097604A (en) * | 1993-07-21 | 1995-01-25 | 黄勇 | Fumigating and washing hemorrhoid curing powder and preparation method thereof |
| CN103768526A (en) * | 2014-01-22 | 2014-05-07 | 安徽思康生物科技有限公司 | External ointment for treating haemorrhoids |
-
2015
- 2015-02-28 CN CN201510091681.1A patent/CN104707041B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1097604A (en) * | 1993-07-21 | 1995-01-25 | 黄勇 | Fumigating and washing hemorrhoid curing powder and preparation method thereof |
| CN103768526A (en) * | 2014-01-22 | 2014-05-07 | 安徽思康生物科技有限公司 | External ointment for treating haemorrhoids |
Non-Patent Citations (1)
| Title |
|---|
| 中药软膏在痔疮术后的应用研究进展;周青等;《山东中医药大学学报》;20110930;第35卷(第05期);第467页第1栏第3段 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104707041A (en) | 2015-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105456989A (en) | Traditional Chinese medicine for eliminating pain and preparation method of traditional Chinese medicine | |
| CN105982976B (en) | Treat bone penetrating fluid of bone and joint diseases and preparation method thereof | |
| CN101816736B (en) | Chinese medicament capsule for curing nasosinusitis | |
| CN104873631A (en) | Traditional Chinese medicinal composition for treating bone diseases, preparation method of traditional Chinese medicinal composition and bone disease therapeutic apparatus | |
| CN104740202A (en) | Medicine for treating skin itch | |
| CN104491220B (en) | A kind of traditional Chinese medicine composition for herpes | |
| CN104707041B (en) | For the care drug of postoperation | |
| CN104383445A (en) | Traumatic injury analgesic | |
| CN104706782A (en) | External tincture for treating bone poliomyelitis and preparation method of external tincture | |
| CN104043089A (en) | Medical biological dressing suppository for treating hemorrhoid | |
| CN104288417A (en) | Traditional Chinese medicine composition for treating dysmenorrhea and preparation method thereof | |
| CN103908600A (en) | Externally-applied medicine for treating rheumatoid arthritis damp-heat blockage symptom as well as preparation method and administration method thereof | |
| CN103656090B (en) | A kind of enema and application thereof for the treatment of ulcerative colitis | |
| CN102949507B (en) | Traditional Chinese medicine lotion for treating lumbocrural pain and preparation method thereof | |
| CN101983682A (en) | Medicament for treating female climacteric metancholia | |
| CN104888104A (en) | Pharmaceutical composition for nursing and treating varicose veins and preparation method of pharmaceutical composition | |
| CN104258308A (en) | Traditional Chinese medicine preparation for treating cholelithiasis | |
| CN103977252A (en) | Ointment for treating hemorrhoids | |
| CN104225282A (en) | Traditional Chinese medicine for treating postpartum headache | |
| CN102836251A (en) | External traditional Chinese medicine used for treating rectal prolapse disease | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN107812091A (en) | A kind of Chinese medicine preparation for treating phlebitis caused by chemotherapeutics and preparation method thereof | |
| CN104324252A (en) | Traditional Chinese medicine preparation for treating sudden dizziness | |
| CN106074956A (en) | A kind of Chinese medicine composition for the treatment of CT enhanced ct scans contrast agent seepage | |
| CN104740035A (en) | Traditional Chinese medicine for treating icteritious hepatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160106 Termination date: 20190228 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |